Income Statement
TREACE MEDICAL CONCEPTS, INC.
TMCI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
212.69 | 209.36 | 187.12 | 141.84 | 94.42 |
|
Cost of Revenue
|
42.94 | 41.09 | 35.18 | 27.52 | 17.83 |
|
Gross Profit
|
169.75 | 168.26 | 151.94 | 114.32 | 76.59 |
|
Operating Expenses
|
223.91 | 223.95 | 203.37 | 149.16 | 93.10 |
|
Research & Development
|
20.28 | 20.59 | 15.44 | 13.60 | 10.20 |
|
Selling, General & Administrative
|
140.88 | 147.64 | 140.89 | 102.58 | 64.47 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-54.15 | -55.69 | -51.43 | -34.84 | -16.51 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
5.32 | 5.30 | 5.20 | 4.40 | 4.10 |
|
Other Non-Op Income / Expense
|
-4.85 | -0.06 | 1.90 | -7.97 | -4.04 |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-59.00 | -55.74 | -49.53 | -42.82 | -20.55 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-43.53 | -47.27 | -46.08 | -32.71 | -15.81 |
|
Earnings Per Share (Basic)
|
-0.93 | -0.90 | -0.81 | -0.77 | - |
|
Diluted EPS
|
-0.93 | -0.90 | -0.81 | -0.77 | - |
|
Weighted Average Shares
|
63.27 | 62.11 | 60.85 | 55.28 | - |
|
Diluted Weighted Avg Shares
|
63.27 | 62.11 | 60.85 | 55.28 | - |
|
Comprehensive Income
|
-59.03 | -55.81 | -49.30 | -42.80 | - |